Free press releases distribution network?

Agency / Source: Biotage

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Biotage Introduces Highly-Selective AFFINILUTE MIP - Biotage (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation
Biotage Introduces Highly-Selective AFFINILUTE MIP

 

PRZOOM - /newswire/ - Charlotte, NC, United States, 2010/07/07 - Biotage (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Highly selective extractions with AFFINILUTE MIPs are considerably simplified resulting in faster, more robust and ultimately lower cost sample preparation.

AFFINILTE MIP columns contain engineered cross-linked polymers that exhibit high affinity and selectivity towards a single compound or class of compounds. They are ideal for the extraction of analytes from complex matrices such as plasma, urine, muscle tissue, food matrices and environmental samples. The selectivity of AFFINILUTE MIPs allows for trace level extraction (
Biotage AFFINILUTE MIP columns offer analytical chemists ultimate selectivity compared with standard solid phase extraction techniques. Unlike other methods, they rely on the specific molecular structure of the analyte for targeted capture resulting in exceptional clean up. AFFINILUTE combines high affinity with standard flow through sample preparation methodology.

The highly selective AFFINILUTE MIP columns serve a wide variety of analytical chemists in environmental, forensic, clinical and food testing laboratories. Typical analytes include Beta-blockers and Beta-agonists, Riboflavin (vitamin B2), triazine herbicides, antibiotics, tobacco specific by-products, amphetamines, fluoroquinolones, nitroimidazoles and more.

Biotage sample preparation products are supported by a wealth of knowledge and experience in method development and support. “Our expertise helps guide customers in choosing the right product and most efficient method that best suits their analytical needs”, says Scott Carr, VP of Commercial Operations. “At Biotage we strive to develop innovative scientific solutions that are simple, reliable and deliver accurate results. This new generation of sample preparation columns reflects Biotage’s expertise and continued commitment to high quality sample preparation.”

For further information please call Biotage or visit biotage.com: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 422 28 1233, other areas please call +46 18 56 57 10.

For further product information contact: Gary Dowthwaite, Analytical Products Manager, IST House, Cardiff CF82 7TS, UK. T: +44 1443 811840 E: Gary.Dowthwaite[.]biotage.com.
For press information contact: Rob Thompson, Director of Marketing Communications.

About Biotage

Biotage (biotage.com) offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. The customers include the world’s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Biotage

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Biotage Introduces Highly-Selective AFFINILUTE MIP

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Rob Thompson - Biotage.com 
704-654-4847 rob.thompson[.]biotage.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Biotage securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Biotage / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today